Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

Auteurs : Ligorio F, Di Cosimo S, Verderio P, Ciniselli CM, Pizzamiglio S, Castagnoli L, Dugo M, Galbardi B, Salgado R, Loi S, Michiels S, Triulzi T, Tagliabue E, El-Abed S, Izquierdo M, de Azambuja E, Nuciforo P, Huober J, Moscetti L, Janni W, Coccia-Portugal MA, Corsetto PA, Belfiore A, Lorenzini D, Daidone MG, Vingiani A, Gianni L, Pupa SM, Bianchini G, Pruneri G, Vernieri C
Jaar : 2022
Journal : J Natl Cancer Inst
Volume : 114
Pagina's : 1720-1727

International consensus on radiotherapy in metastatic non-small cell lung cancer.

Auteurs : Zhu Z, Ni J, Cai X, Su S, Zhuang H, Yang Z, Chen M, Ma S, Xie C, Xu Y, Li J, Ge H, Liu A, Zhao L, Rao C, Bi N, Hui Z, Zhu G, Yuan Z, Wang J, Zhou W, Rim CH, Navarro-Martin A, Vanneste BGL, Ruysscher D, Choi JI, Jassem J, Chang JY, Kepka L, Käsmann L, Milano MT, Van Houtte P, Suwinski R, Traverso A, Doi H, Suh YG, Noël G, Tomita N, Kowalchuk RO, Sio TT, Li B, Lu B, Fu X
Jaar : 2022
Journal : Transl Lung Cancer Res
Volume : 11
Pagina's : 1763-1795

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.

Auteurs : Laurent A, Marechal R, Farinella E, Bouazza F, Charaf Y, Gay F, Van Laethem JL, Gonsette K, El Nakadi I
Jaar : 2022
Journal : Thorac Cancer
Volume : 13
Pagina's : 2699-2710

Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Auteurs : Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C
Jaar : 2022
Journal : Target Oncol
Volume : 17
Pagina's : 497-505

Primary Breast Tuberculosis Mastitis Manifested as Nonhealing Abscess.

Auteurs : Hoang H, El-Helou E, Pop CF, Shall A, Zaiter M, Naccour J, Nguyen TTH, Ho XD, Nguyen VC
Jaar : 2022
Journal : Surg J (N Y)
Volume : 8
Pagina's : e123-e126

Persistent Left Superior Vena Cava Associated with Right Aberrant Subclavian Artery Detected during Totally Implantable Vascular Access Device Insertion.

Auteurs : El-Helou E, Zaiter M, Shall A, Sleiman Y, Liberale G, Pop CF
Jaar : 2022
Journal : Surg J (N Y)
Volume : 8
Pagina's : e117-e122

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.

Auteurs : Gueuning C, Ameye L, Loizidou A, Grigoriu B, Meert AP
Jaar : 2022
Journal : Support Care Cancer
Volume : 30
Pagina's : 7635-7643

Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?

Auteurs : Benkhaled S, Koshariuk O, Van Esch A, Remouchamps V
Jaar : 2022
Journal : Rep Pract Oncol Radiother
Volume : 27
Pagina's : 490-499

Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.

Auteurs : Li WB, Bouvier-Capely C, Saldarriaga Vargas C, Andersson M, Madas B
Jaar : 2022
Journal : Radiat Environ Biophys
Volume : 61
Pagina's : 579-596

Psychological factors associated with clinical fear of cancer recurrence in breast cancer patients in the early survivorship period.

Auteurs : Waroquier P, Delevallez F, Razavi D, Merckaert I
Jaar : 2022
Journal : Psychooncology
Volume : 31
Pagina's : 1877-1885

Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.

Auteurs : Baré M, Poeta S, Fernandes P, Jourani Y, Otte FX, Van Brussel S, Van Gestel D, Van den Begin R
Jaar : 2022
Journal : Phys Imaging Radiat Oncol
Volume : 23
Pagina's : 127-133

Bufalin for an innovative therapeutic approach against cancer.

Auteurs : Soumoy L, Ghanem GE, Saussez S, Journe F
Jaar : 2022
Journal : Pharmacol Res
Volume : 184
Pagina's : 106442

A randomized controlled trial assessing behavioral, cognitive, emotional and physiological changes resulting from a communication skills training in physicians caring for cancer patients.

Auteurs : Libert Y, Peternelj L, Bragard I, Marchal S, Reynaert C, Slachmuylder JL, Razavi D
Jaar : 2022
Journal : Patient Educ Couns
Volume : 105
Pagina's : 2888-2898

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

Auteurs : Thouvenin J, Alhalabi O, Carlo M, Carril-Ajuria L, Hirsch L, Martinez-Chanza N, Négrier S, Campedel L, Martini D, Borchiellini D, Chahoud J, Lodi M, Barthélémy P, Hasanov E, Hahn AW, Gil T, Viswanathan SR, Bakouny Z, Msaouel P, Asim Bilen M, Choueiri TK, Albiges L, Tannir NM, Malouf GG
Jaar : 2022
Journal : Oncologist
Volume : 27
Pagina's : 1041-1047

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.

Auteurs : Arboleda B, Bartsch R, de Azambuja E, Hamilton E, Harbeck N, Klemp J, Knauer M, Kuemmel S, Mahtani R, Schwartzberg L, Villarreal-Garza C, Wolff A
Jaar : 2022
Journal : Oncologist
Volume : 27
Pagina's : 722-731

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

Auteurs : Rugo HS, Tolaney SM, Loirat D, Punie K, Bardia A, Hurvitz SA, OShaughnessy J, Cortés J, Diéras V, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo M, Itri LM, Kalinsky K
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 98

Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis.

Auteurs : Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, Dupont F, Campbell P, Lambrechts D, Dirix L, Sotiriou C, Ignatiadis M
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 79

The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.

Auteurs : Isnaldi E, Richard F, De Schepper M, Leduc S, Maetens M, Geukens T, Van Baelen K, Nguyen HL, Rouas G, Zoppoli G, Cardoso F, Sotiriou C, Larsimont D, Floris G, Biganzoli E, Desmedt C
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 90

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Auteurs : Carey LA, Loirat D, Punie K, Bardia A, Diéras V, Dalenc F, Diamond JR, Fontaine C, Wang G, Rugo HS, Hurvitz SA, Kalinsky K, OShaughnessy J, Loibl S, Gianni L, Piccart M, Zhu Y, Delaney R, Phan S, Cortés J
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 72

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.

Auteurs : Agostinetto E, Ameye L, Martel S, Aftimos P, Pondé N, Maurer C, El-Abed S, Wang Y, Vicente M, Chumsri S, Bliss J, Kroep J, Colleoni M, Petrelli F, Del Mastro L, Moreno-Aspitia A, Piccart M, Paesmans M, de Azambuja E, Lambertini M
Jaar : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pagina's : 87